Finally, we investigated the functional role of SFRP2 in SCO development based on our initial findings showing increased SFRP2 expression in fibroblasts isolated from AHO patients, which we also observed in our mouse model. The gene discussed is SFRP2; the disease is pseudohypoparathyroidism type 1A.